Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (5y) (2017 - 2026)
Zimmer Biomet Holdings (ZBH) FCF Payout Ratio Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Zimmer Biomet Holdings | 18.13 Bn | 17.70 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.44% |
| Dec 31, 2025 | -9.99% |
| Sep 30, 2025 | -1.58% |
| Jun 30, 2025 | 17.18% |
| Mar 31, 2025 | 3.24% |
| Dec 31, 2024 | -4.52% |
| Sep 30, 2024 | 8.14% |
| Jun 30, 2024 | -5.11% |
| Mar 31, 2024 | 7.46% |
| Dec 31, 2023 | -8.34% |
| Sep 30, 2023 | 11.36% |
| Jun 30, 2023 | 8.54% |
| Mar 31, 2023 | 12.96% |
| Dec 31, 2022 | 15.39% |
| Sep 30, 2022 | 1.90% |
| Jun 30, 2022 | 6.93% |
| Mar 31, 2022 | -2.79% |
| Dec 31, 2021 | 15.69% |
| Sep 30, 2021 | -4.01% |
| Jun 30, 2021 | -2.42% |